AI-assisted PSMA PET/CT Solution
Comprehensive AI-assisted PSMA PET/CT solution for improved prostate cancer diagnosis accuracy
Software · Cloud SaaSCompany source
Company profile
About Mirada Medical
Mirada Medical is a global innovator in medical imaging software dedicated to accelerating cancer care through personalized image-guided treatment solutions. The company's mission centers on making cancer care universally available, free of delays, and equipped with the latest techniques to improve patient outcomes and experience. Medical imaging sits at the heart of their approach, combining scientific advancement, technical innovation, and clinical expertise. The company offers three flagship products across different clinical domains. Mirada XD is an integrated vendor-neutral software platform for diagnostic reading of PET/CT, PET/MR, nuclear medicine, and image fusion, featuring advanced deformable registration and quantification tools. Mirada RTx provides comprehensive image registration and visualization capabilities for radiotherapy professionals, offering advanced workflows without requiring costly treatment planning systems. Simplicit90Y is specialized dosimetry software designed to accelerate planning and improve Y-90 SIRT workflows for interventional radiology. Mirada Medical's solutions are powered by world-class deformable registration technology and accurate quantification tools, supporting protocols like PERCIST, RECIST, WHO, and Total Lesion Glycolysis. The company serves radiation oncologists, diagnostic radiologists, and interventional radiologists globally, with hundreds of users worldwide. Their commitment extends beyond software delivery through comprehensive customer success programs, clinical onboarding, and community engagement initiatives that connect users with technical experts and best practices from advanced clinics worldwide.
Company description Mirada Medical official website
Primary marketMedical Imaging & Radiology
Commercial modelCommercial information available on request
Company presenceOfficial website
Work at Mirada Medical?
Claim this listing Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Where the Company operates
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Clinical focus
- Cancer
- Lymphoma (Hodgkin's and non-Hodgkin's)
- Oncology
- Prostate cancer
Who it serves
- Diagnostic Imaging Centers
- Health Systems
- Hospitals
- Nuclear Medicine Departments
- Radiation Oncology Centers
Deployment & integration
Cloud Saas · On Premise deployment with recorded integration context.
Geographic context
MarketsGlobal · United Kingdom · United States
Company sourceOfficial website
Company milestones
Platform expansion
Awarded £500,000 grant from Innovate UK's Advancing Precision Medicine program (June 2024) for AI-assisted PSMA PET/CT development. Recognized as Top 100 Digital Health Company by DIT. Received further investment from Apposite Capital to advance precision cancer care.
Partnerships
Recorded partners
- Alliance Medical Group
- Apposite Capital (investor)
- Leeds Teaching Hospitals NHS Trust
- Newcastle upon Tyne Hospitals NHS Foundation Trust
- Ramsoft
- Sorna Corporation
- University Hospitals Bristol and Weston NHS Foundation Trust
02 · Flagship portfolio
Products, workflows, and platform capabilities
Selected source-backed Company products and the available commercial context.
Mirada RTx
Trusted, accurate and comprehensive image registration and visualization software package for radiotherapy professionals
Software · On PremiseCompany source
Mirada XD
Integrated vendor-neutral software for diagnostic reading of PET/CT, PET/MR, nuclear medicine and image fusion
Software · Cloud SaaSCompany source
Simplicit90Y
Customized, easy-to-use dosimetry software for accelerating Y-90 SIRT workflows
Software · On PremiseCompany source
03 · Research intelligence
Research Intelligence evidence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Evidence position
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Publications & preprints
Comparative analysis of PSMA-RADS Version 2.0 versus bone uptake metastatic probability (BUMP) score for characterising focal bone uptake on [18F]PSMA-1007 PET/CT in prostate cancer - a multicentre evaluation.European journal of nuclear medicine and molecular imaging · Sep 1, 2026
Examining explainable artificial intelligence in TNM staging with PET-CT: a user-centred observation study.La Radiologia medica · Jul 13, 2026
Deep learning-assisted interactive contouring of lung cancer: Impact on contouring time and consistency.Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology · Nov 1, 2024
Fully automated radiotherapy treatment planning: A scan to plan challenge.Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology · Nov 1, 2024
An approach to generate synthetic 4DCT datasets to benchmark Mid-Position implementations.Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB) · Oct 1, 2023
Geometric and dosimetric analysis of CT- and MR-based automatic contouring for the EPTN contouring atlas in neuro-oncology.Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB) · Oct 1, 2023
Clinical validation
Clinical-trial records
No linked records are currently available.
Regulatory
Regulatory records
Workflow BoxK181572 · 510k · Jul 10, 2018
04 · Company-reported outcomes
Outcomes and case studies
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
Improved diagnostic accuracy
AI-assisted PSMA PET/CT solution for prostate cancer diagnosis
Enhanced clinical workflow efficiency
Standardized reporting and automation to address large imaging volumes and staffing challenges
Better patient stratification
Precise patient stratification for effective treatment options including radiopharmaceutical therapies
Newcastle upon Tyne Hospitals NHS Foundation Trust
Clinical partner for PSMA PET/CT AI solution development to improve prostate cancer diagnosis and treatment decisions
University Hospitals Bristol and Weston NHS Foundation Trust
Clinical partner for PSMA PET/CT AI solution development for prostate cancer treatment transformation
Alliance Medical Group
Collaboration on NCIMI project to develop and deploy next generation of intelligent and integrated imaging solutions for diagnostics applications
Leeds Teaching Hospitals NHS Trust
NCIMI lymphoma case study - investigating the role of AI and Deep Learning in diagnostic nuclear medicine for lymphoma diagnosis and treatment
05 · Leadership
Leadership team
Leadership profiles and professional links from the current Company record.
06 · Company updates
Updates from Mirada Medical
Recent articles published on Mirada Medical's official website.
The NCIMI lymphoma case study video - National Consortium of Intelligent Medical Imaging
Read on Mirada MedicalCelebrating International Women's Day at Mirada.
Read on Mirada MedicalEnd to end AI assisted PSMA PET/CT reporting workflow. Innovate UK advanced precision medicine programme
Read on Mirada MedicalIntroducing research by Mirada Scientist, Georgia Ionescu
Read on Mirada MedicalConcertAI's TeraRecon Adds Mirada Medical to its AI Partner Program
Read on Mirada Medical07 · HAIC coverage
Coverage and analysis
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Company sources and channels
Curated official destinations from the active Company record.
09 · Market pathway
Additional Companies in this Market
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Medical Imaging & Radiology
Companies that apply AI to analyze medical images for diagnostic purposes, workflow optimization, or clinical decision support. Covers general radiology (X-rays, CT scans, MRIs, ultrasounds) across multiple organ systems, as well as specialized imaging in ophthalmology and dermatology.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market
10 · Pro research
Coming soon
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Deeper Company research is coming soon.
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.